Inhibition of advanced glycation by flavonoids. A nutritional implication for preventing diabetes complications?;Inhibition de la glycation avancée par les flavonoïdes. Implication nutritionnelle dans la prévention des complications du diabète?

Journal de la Societe de Biologie

Volumn 201, Issue 2, 2007, Pages 189-198

  Urios, Paul ^a,b   Grigorova Borsos, Anne Marie ^a   Peyroux, Jacques ^a   Sternberg, Michel ^a,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BICHAT HOSPITAL   (France)

^c HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ARGININE; DRUG DERIVATIVE; FLAVONOID; LYSINE; PENTOSIDINE;

CHEMISTRY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG ANTAGONISM; HUMAN; REVIEW;

ARGININE; DIABETES COMPLICATIONS; DIETARY SUPPLEMENTS; FLAVONOIDS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LYSINE;

VITACEAE;

EID: 35748980291     PISSN: 12950661     EISSN: None     Source Type: Journal    
DOI: 10.1051/jbio:2007024     Document Type: Review

References (46)

1. Aherne S. A. & O'Brien N. M., Dietary flavonols: chemistry, food content, and metabolism. Nutrition, 2002, 18, 75-81.
2. Balant L., Burki B., Wermeille M. & Golden G., Comparison of some pharmacokinetic parameters of (+)-cyanidanol-3 obtained with specific and non-specific analytical methods. Arzneimitteforschung, 1979, 29, 1758-1762.
3. Carando S., Teissedre P.-L., Pascual-Martinez L. & Cabanis J.-C., Levels of flavan-3-ols in french wines. J. Agric. Food. Chem., 1999, 47, 4161-4166.
4. De Groot H. & Rauen U., Tissue injury by reactive oxygen species and the protective effects of flavonoids. Fundam. Clin. Pharmacol., 1998, 12, 249-255.
5. De Pascual-Teresa S., Santos-Buelga C. & Rivas-Gonzalo J. C., Quantitative analysis of flavan-3-ols in spanish foodstuffs and beverages. J. Agric. Food Chem., 2000, 48, 5331-5337.
6. De Vries J. H., Hollman P. C., van Amersfoort I., Olthof M. R. & Katan M. B., Red wine is a poor source of bioavailable flavonols in men. J. Nutr., 2001, 131, 745-748.
7. Elgawish A., Glomb M., Friedlander M. A. & Monnier V. M., Involvement of hydrogen peroxide in collagen crosslinking by high glucose in vitro and in vivo. J. Biol. Chem., 1996, 271, 12964-12971.
8. Fuleki T. & Ricardo-Da-Silva J. M., Effects of cultivar and processing method on the contents of catechins and procyanidins in grape juice. J. Agric. Food Chem., 2003, 51, 640-646.
9. Graefe E. U., Wittig J., Mueller S., Tiethling A. K., Uehleke B., Drewelow B., Pforte B., Jacobasch G., Derendorf H. & Veit M., Pharmacokinetics and bioavailability of quercetin glycosides in humans. J. Clin. Pharmacol., 2001, 41, 492-499.
10. Gu L., Kelm M., Hammerstone J. F., Beecher G., Holden J., Haytowitz D. & Prior R. L., Screening of foods containing proanthocyanidins and their structural characterization using LC-MS/MS and thiolytic degradation. J. Agric. Food Chem., 2003, 51, 7513-7521.
11. Hakkinen S. H., Karenlampi S. O., Heinonen M., Mykkanen H. M. & Torronen A. R., Content of the flavanols quercetin, myricetin, and kaempferol in 25 edibles berries. J. Agric. Food Chem., 1999, 47, 2274-2279.
12. Hammerstone J. F., Lazarus S. A. & Schmitz H. H., Procyanidin content and variation in some commonly consumed foods. J. Nutr., 2000, 130 (Suppl.), 2086S-2092S.
13. Hertog M. G. L., Hollman P. C. H. & Katan M. B., Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in The Netherlands. J. Afric. Food Chem., 1992, 40, 2379-2383.
14. Hertog M. G. L., Hollman P. C. H. & van de Putte B., Content of potentially anti-carcinogenic flavonoids of tea infusions, wines, and fruit juices. J. Agric. Food Chem., 1993, 41, 1242-1246.
15. Holt R. R., Lazarus S. A., Cameron Sullards M., Yan Zhu Q., Schramm D. D., Hammerstone J. F., Fraga C. G., Schmitz H. H. & Keen C. L., Procyanidin dimer B2 [epicatechin-(4b-8)-epicatechin in human plasma after the consuption of a flavanol-rich cocoa. Am. J. Clin. Nutr., 76, 798-804.
16. Kris-Etherton P. M., Lefevre M., Beecher G. R., Gross M. D., Keen C. L. & Etherton T. D., Bioactive compounds in nutrition and health-research methodologies for establishing biological function: the antioxidant and anti-inflammatory effects of flavonoids on atherosclerosis. Annu. Rev. Nutr., 2004, 24, 511-538.
17. Lamuela-Raventos R. M., Andres-Lacueva C., Permanyer J. & Izquierdo-Pulido M., More antioxidants in cocoa. J. Nutr., 2001, 131, 834
18. Lee M.-J., Wang Z.-Y., Li H., Chen L., Sun Y., Gobbo S., Balentine D. A. & Yang C. S., Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol. Biomark. Prev., 1995, 4, 393-399.
19. Leenen R., Roodenburg A. J., Tijburg L. B. & Wiseman S. A., A single dose of tea with or without milk increases plasma antioxidant activity in humans. Eur. J. Clin. Nutr., 2000, 54, 87-92.
20. Maiani G., Serafini M., Salucci M., Azzini E. & Ferro-Luzzi A., Application of a new high-performance liquid chromatographic method for measuring selected polyphenols in human plasma. J. Chromatogr B. Biomed. Sci. Appl., 1997, 692, 311-317.
21. Manach C., Scalbert A., Morand C., Remesy C. & Jimenez L., Polyphenols: food sources and bioaviability. Am. J. Clin. Nutr., 2004, 79, 727-747.
22. Manach C., Williamson G., Morand C., Scalbert A. & Remesy C., Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Nutr., 2005, 81 (suppl.), 230S-242S.
23. Monnier V. M., Bautista O., Kenny D., Sell D. R., Fogarty J., Dahms W., Cleary P. A., Lachin J., Genuth S. & the DCCT Skin Collagen Ancillary Study Group, Skin collagen glycation, glycoxidation, and cross-linking are lower in subjects with long-term intensive versus conventional therapy of type-1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. Diabetes, 1999a, 48, 870-880.
24. Monnier V., Fogarty J. F., Monnier C. S. & Sell D. R., Glycation, glycoxidation and other Maillard recation products. In: Byung Pal Yu (eds) Methods in aging research., CRC Press, New York, pp. 657-681.
25. Monnier V. M., Intervention against the Maillard reaction in vivo. Arch. Biochem. Biophys., 2003, 419, 1-15.
26. Nakagawa K., Okuda S. & Miyazawa T., Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci. Biotechnol. Biochem., 1997, 61, 1981-1985
27. Odetti P. R., Borgoglio A., De Pascale A., Rolandi R. & Adezati L., Prevention of diabetes-increased aging effect on rat collagen-linked fluorescence by aminoguanidine and rutin. Diabetes, 1990, 39, 796-801.
28. Olthof M. R., Hollman P. C., Vree T. B., Katan M. B., Bioavailabilities of quercetin-3-glucoside and quercetin-4′-glucoside do not differ in humans. J. Nutr., 130, 1200-1203
29. Peyroux J. & Sternberg M., Advanced glycation end products (AGEs): pharmacological inhibition in diabetes. Path. Biol., 2006, 54, 405-419.
30. Price D. L., Rhett P. M., Thorpe S. R. & Baynes J. W., Chelating activity of advanced glycation end-product inhibitors. J. Biol. Chem., 2001, 276, 48967-48972.
31. Sano A., Yamakoshi J., Tokutake S., Tobe K., Kubota Y. & Kikuchi M., Procyanidin B1 is detected in human serum after intake of proanthocyanidin-rich grape seed extract. Biosci. Biotechnol. Biochem., 2003, 67, 1140-1143.
32. Scalbert A. & Williamson G., Dietary intake and bioavailability of polyphenols. J. Nutr., 2000, 130, 2073S-2085S.
33. Sell D. R., Lapolla A., Odetti P., Fogarty J. & Monnier V. M., Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes, 1992, 41, 1286-1292.
34. Spencer J. P., Chaudry F., Pannala A. S., Srai S. K., Debnam E. & Rice-Evans C., Decomposition of cocoa procyanidins in the gastric milieu. Biochem. Biophys. Res. Comm., 2000, 272, 236-241.
35. Sternberg M. C., M'Bemba J., Urios P., Borsos A. M., Roux A., Adam C., Berne C., Selam J. L. & Slama G., Skin-Collagen Pentosidine and fluorescence at 370/440 nm as markers of diabetes duration and complications in a french population. Diabetologia, 2003, 46 (Suppl. 2), A406.
36. Sternberg M., Borsos A. M., Roux A., Adam C. & Urios P., Compared inhibition of pentosidine formation in type-I collagen incubated with glucose by catechin, myricetin, kaempferol and quercetin: role of flavonoid strucrure. Diabetologia, 2002, 45 (suppl. 2), 393.
37. Stitt A., Gardiner T. A., Anderson N. L., Canning P., Frizzell N, Duffy N., Boyle C., Januszewski A. S., Chachich M., Baynes J. W. & Thorpe S. R., The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes, 2002, 51, 2826-2832.
38. Tourino S., Selga A., Jimenez A., Julia L., Lozano C., Lizarraga D., Cascante M. & Torres J. L., Procyanidin fractions from pine (Pinus pinaster) bark: radical scavenging power in solution, antioxydant activity in emulsion, and antiproliferative effect in melanoma cells. J. Agric. Food Chem., 2005, 53, 4728-4735.
39. Urios P., Grigorova-Borsos A. M., Feing-Kwong-Chan S. & Sternberg M., Quercetin and rutin inhibit pentosidine formation on type-I collagen incubated with glucose. Exp. Clin. Endocrinol. Diabetes, 2000a, 18/5, A11.
40. Urios P, Kassab I, Borsos AM, Guillot R, Peyroux J, Sternberg M (2000b) Long-term treatment with a purified micronized flavonoid fraction reduces urinary albumin clearance and restores albuminemia in normotensive and hypertensive diabetic rats. Diabetes Res. Clin. Pract., 2000b, 50 (suppl. 1), S362.
41. Urios P., Grigorova-Borsos A.-M. & Sternberg M., Unexpected elevation of pentosidine formation in collagen incubated with glucose by low concentrations of the AGE-inhibitor aminoguanidine. Diabetologia, 2004, 47, 959-961.
42. Urios P., Grigorova-Borsos A.-M. & Sternberg M., Flavonoids inhibit the formation of the cross-linking AGE pentosidine in collagen incubated with glucose, according to their structure. Eur J. Nutr., 2007, 46, 139-146.
43. Vertommen J., Van Den Enden M., Simoens L. & De Leew I., Flavonoid treatment reduces glycation and lipid peroxidation in experimental diabetic rats. Phytotherapy Research, 1994, 8, 430-432.
44. Waterhouse A. L., Wine phenolics. Ann. NY Acad. Sci., 2002, 957, 21-36.
45. Woessner J. F., The determination of hydroxyproline and protein samples containing small proportions of this imino acid. Arch. Biochem. Biophys., 1961, 93, 440-447.
46. Yang Y. & Chien M., Characterization of grape procyanidins using high-performance liquid chromatography/mass spectrometry and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J. Agric. Food Chem., 2000, 48, 3990-3996.